Normal and clonal B lineage cells can be distinguished by their differential expression of B cell antigens and adhesion molecules in peripheral blood from multiple myeloma (MM) patients diagnostic and clinical implications

Clinical and Experimental Immunology

Volumn 112, Issue 3, 1998, Pages 410-418

  Luque, R ^a   Brieva, J A ^b   Moreno, A ^a   Manzanal, A ^a   Escribano, L ^a   Villarrubia, J ^a   Velasco, J L ^a   Lopez Jimenez J ^a   Cervero C ^a   Otero, M J ^c   Martinez J ^d   Bellas, C ^a   Roldan E ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

^c HOSPITAL CENTRAL DE LA DEFENSA GÓMEZ ULLA   (Spain)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

B cell; Myeloma; Peripheral blood; Phenotype

Indexed keywords

B LYMPHOCYTE ANTIGEN; CD19 ANTIGEN; CD20 ANTIGEN; CD22 ANTIGEN; CD24 ANTIGEN; CD38 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; CELL ADHESION MOLECULE; DNA; HERMES ANTIGEN; IMMUNOGLOBULIN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; PADGEM PROTEIN;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; LYSIS; MULTIPLE MYELOMA; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANTIGENS, CD; B-LYMPHOCYTES; CELL ADHESION MOLECULES; CELL DIFFERENTIATION; CELL LINEAGE; GENE REARRANGEMENT, B-LYMPHOCYTE; GENES, IMMUNOGLOBULIN; HUMANS; IMMUNOPHENOTYPING; MULTIPLE MYELOMA; RECEPTORS, ANTIGEN, B-CELL; TUMOR MARKERS, BIOLOGICAL;

EID: 15144359887     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00600.x     Document Type: Article

References (43)

1. Barlogie B, Epstein J, Selvanayagam P et al. Plasma cell myeloma: new biological insights and advances in therapy. Blood 1989; 73:865-79.
2. Billadeau D, Quam L, Thomas W et al. Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients. Blood 1992; 80:1818-24.
3. Witzig TE, Kimlinger TK, Greipp PR. Detection of peripheral blood myeloma cells by three-color flow cytometry. Curr Top Microbiol Immunol 1994; 194:3-8.
4. Jensen GS, Mant MJ, Belch AJ et al. Selective expression of CD45 isoforms defines CALLA+ monoclonal B-lineage cells in peripheral blood from myeloma patients as late stage B cells. Blood 1991; 78:711-9.
5. Boccadoro M, Omedé P, Massaia M et al. Human myeloma: several subsets of circulating lymphocytes express plasma-cell associated antigens. Eur J Hematol 1988; 40:299-304.
6. + blood B cell levels in myeloma. Blood 1995; 86:4000 (letter).
7. Dillman RO, Royston I, Meserve BL et al. Alterations of peripheral blood B-lymphocyte populations in plasma cell disorders. Cancer 1981; 48:2211-7.
8. Tienhaara A, Pelliniemi TT. Peripheral blood B lymphocytes in multiple myeloma. Acta Haematol 1994; 91:57-61.
9. King MA, Radicchi MA. Monitoring circulating B cells in patients with multiple myeloma at diagnosis or in plateau phase: how prevalent is light chain isotype suppression? Br J Hematol 1992; 81:218-22.
10. Cassel A, Leibovitz N, Hornstein L et al. Evidence for the existence of circulating monoclonal B-lymphocytes in multiple myeloma patients. Exp Hematol 1990; 18:1171-3.
11. Clofent G, Klein B, Commes T et al. No detectable malignant B-cells in the peripheral blood of patients with multiple myeloma. Br J Hematol 1989; 71:357-61.
12. Levy Y, Schmitt C, Tsapis A et al. Phenotype and immunoglobulin gene configuration of blood B cells from patients with multiple myeloma. Clin Exp Immunol 1991; 84:435-9.
13. Chen BJ, Epstein J. Circulating clonal lymphocytes in myeloma constitute a minor subpopulation of B cells. Blood 1996; 87:1972-6.
14. Pilarski LM, Jensen GS. Monoclonal circulating B cells in multiple myeloma. A continuously differentiating, possibly invasive, population as defined by expression of CD45 isoforms and adhesion molecules. Hematol Oncol Clin North Am 1992; 6:297-322.
15. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346:425-34.
16. Jensen GS, Belch AR, Kherani F et al. Restricted expression of immunoglobulin light chain mRNA and of the adhesion molecule CD11b on circulating monoclonal B lineage cells in peripheral blood of myeloma patients. Scan J Immunol 1992; 36:843-53.
17. Billudeau D, Van Ness B, Kimlinger Tet al. Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smouldering multiple myeloma, and active myeloma. Blood 1996; 88:289-96.
18. Witzig TE, Kimlinger TK, Ahmann GJ et al. Detection of myeloma cells in the peripheral blood by flow cytometry. Cytometry 1996; 26:113-20.
19. Durie BGM, Salmon SE. A clinical staging system for multiple myeloma. Cancer 1975; 36:842-54.
20. Van Zaanen HCT, Vet RJWM, De Jong CM et al. A simple and sensitive method for determining plasma cell isotype and monoclonality in bone marrow using How cytometry. Br J Haematol 1995; 91:55-59.
21. Pellat-Deceunynck C, Bataille R, Robillard N et al. Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells. Blood 1994; 84:2597-603.
22. Krömer E, Grossmüller F. Light scatter based lymphocyte gate - helpful tool or source of error? Cytometry 1994; 15:87-89.
23. Sun R-X, Lu Z-Y, Wijdenes J et al. Large scale and clinical grade purification of syndecan-1+ malignant plasma cells. J Immunol Methods 1997; 205:73-79.
24. Manzanal A, Santon A, Oliva H et al. Evaluation of clonal immunoglobulin heavy chain rearrangements in Hodgkin's disease using the polymerase chain reaction (PCR). Histopathol 1995; 27:21-25.
25. Greipp PR, Raymond NM, Kyle RA et al. Multiple myeloma: significance of plasmoblastic subtype in morphological classification. Blood 1985; 65:305-10.
26. King MA, Nelson DS. Tumor cell heterogeneity in multiple myeloma: antigenic, morphologic, and functional studies of cells from blood and bone marrow. Blood 1989; 73:1925-35.
27. Duperray C, Bataille R, Boiron JM et al. No expansion of the pre-B and B-cell compartments in the bone marrow of patients with multiple myeloma. Cancer Res 1991; 51:3224-8.
28. Kraal G, Weissman IL, Butcher EC. Memory B cells express a phenotype consistent with migratory competence after secondary but not short-term primary immunization. Cell Immunol 1988; 115:78-87.
29. Bevilacqua, Nelson. Selectins. J Clin Invest 1993; 91:379-87.
30. Butcher EC. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 1991; 67:1033-6.
31. Jensen GS, Belch AR, Mant MJ et al. Expression of multiple β1 integrins on circulating monoclonal B cells in patients with multiple myeloma. Am J Hematol 1993; 43:29-36.
32. Alberti S, Parks DR, Herzenberg LA. A single laser method for subtraction of cell autofluorescence in flow cytometry. Cytometry 1997; 8:114-9.
33. Hoover RG, Hickman S, Gebel HM et al. Expansion of Fc receptor-bearing T lymphocytes in patients with immunoglobulin G and immunoglobulin A myeloma. J Clin Invest 1981; 67:308-11.
34. Hoover RG, Lary C, Page R et al. Autoregulatory circuits in myeloma. Tumor cell cytotoxicity mediated by soluble CD16. J Clin Invest 1995; 95:241-7.
35. Kay NE, Leong T, Kyle RA et al. Circulating blood B cells in multiple myeloma: analysis and relationship to circulating clonal cells and clinical parameters in a cohort of patients entered on the Eastern Cooperative Oncology group phase III E9486 clinical trial. Blood 1997; 90:340-5.
36. Pellat-Deceunynck C, Barillé S, Puthier D et al. Adhesion molecules on human myeloma cells: significant changes in expression related in malignancy, tumor spreading and immortalization. Cancer Res 1996; 55:3647-53.
37. Kosmo MA, Gale RP. Plasma cell leukemia. Semin Hematol 1987; 24:202-8.
38. Risau W. Differentiation of endothelium. FASEB J 1995; 9:926-33.
39. Papayannopoulou T, Craddock C, Nakamoto B et al. The VLA-4/ VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen. Proc Natl Acad Sci USA 1995; 92:9647-51.
40. Simmons PJ, Masinovsky B, Longenecker BM et al. Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. Blood 1992; 80:388-95.
41. Corradini P, Voena C, Astolfi M et al. High-dose sequential chemoradiotherapy in multiple myeloma: residual tumor cells are detectable in bone marrow and peripheral blood cell harvests and after autografting. Blood 1995; 85:1596-602.
42. Witzig TE, Gertz MA, Pineda AA et al. Detection of monoclonal plasma cells in the peripheral blood stem cell harvest of patients with multiple myeloma. Br J Haematol 1995; 89:640-2.
43. + cells expanded in vitro. Exp Hematol 1994; 22:1171-8.